Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients

Documenti analoghi

• Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )
  di: John Armato, et al.
  Pubblicazione: (2026)
• Differential effect of endogenous glucagon‐like peptide‐1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery
  di: Henri Honka, et al.
  Pubblicazione: (2024)
• Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non‐diabetic chronic kidney disease
  di: Victor Wasehuus, et al.
  Pubblicazione: (2025)
• Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
  di: Kyung Ah Han, et al.
  Pubblicazione: (2024)
• Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study
  di: In‐Kyung Jeong, et al.
  Pubblicazione: (2024)